Quintuple deglycosylation mutant of simian immunodeficiency virus SIV mac239 in rhesus macaques: Robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain

Journal of Virology

Volumn 75, Issue 9, 2001, Pages 4023-4028

  Mori, K ^a   Yasutomi, Y ^a   Ohgimoto, S ^a   Nakasone, T ^a   Takamura, S ^a   Shioda, T ^a   Nagai, Y ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN DERIVATIVE; GLYCOPROTEIN GP 120; LIVE VACCINE; NEUTRALIZING ANTIBODY;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEGLYCOSYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; TISSUE CULTURE; VIRUS INFECTION; VIRUS LOAD; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALS; CHRONIC DISEASE; GLYCOSYLATION; HIV ENVELOPE PROTEIN GP120; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MUTAGENESIS; POLYSACCHARIDES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; VIRUS REPLICATION;

EID: 0035051927     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.9.4023-4028.2001     Document Type: Article

References (29)

1. Induction of MHC-IIDR expression on circulating CD8+ lymphocytes in macaques infected with SIVmac239 nef-open but not with its nef-deletion mutant
2. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
3. T lymphocyte responses in HIV-1 infection: Implications for vaccine development
4. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies
5. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
6. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice
7. Strategies used by human immunodeficiency virus that allow persistent viral replication
8. Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines
9. Humoral immunity to HIV, SIV, and SHIV
10. Virus-specific CD8+ T-cell memory determined by clonal burst size
11. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface
12. Protective immunity induced by live attenuated simian immunodeficiency virus
13. Importance of the nef gene for maintenance of high virus loads and for development of AIDS
14. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression
15. Cytotoxic T-cell memory without antigen
16. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1
17. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
18. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
19. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus
20. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239
21. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection
22. Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity
23. The neutralizing antibody response to HIV-1: Viral evasion and escape from humoral immunity
24. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus
25. Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein
26. A role for carbohydrates in immune evasion in AIDS
27. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR5 coreceptor recognition
28. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus
29. + lymphocyte response in acutely infected rhesus monkeys